| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |